Statistical analysis
We reported CVR separately as ipsilateral and contralateral values to avoid that mean values could obscure side differences. 41 Due to the wide range of reported CVR measured by TCD and AZ in healthy subjects [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] and patients with UIA 20 , we studied CVR as a continuous variable. Effects are reported per percentage point change in CVR. Midline aneurysms were allocated according to chosen side of approach for treatment. Standard t-tests and multiple regression analyses (adjusted for age, sex, hypertension, smoking, aneurysm diameter and treatment modality) were carried out to examine the relationship between CVR and rupture status.
We then compared clinical, radiographical and sonographical variables of patients with and without DCIclinical, with chi-squared or Fisher's exact test, as appropriate. Next, we assessed the predictive potential of both contralateral and ipsilateral CVR for DCIclinical and DCIinfarction, to decide which measure of CVR was most appropriate to use in patients with multiple measurement (first, lowest, or within-patient average of all exams). A priori, we chose the lowest or first measured CVR as the exposure (more convenient in clinical use). T-test was used to compare CVR in aSAH patients with and without DCIclinical or DCIinfarction, and to assess side differences.
Simple logistic regression analyses were conducted for both DCIclinical and DCIinfarction versus both within-patient average CVR and lowest measured contralateral CVR. Further, box plots were constructed, based on the lowest measured iCVR and cCVR for UIA, aSAH without DCIclinical, and aSAH with DCIclinical.
From this, two prediction models for DCIclinical were created. Model I included WFNS, modified CT Fisher scale, age, sex, smoking, and hydrocephalus, all variables suspected to affect risk of DCIclinical. Model II included all variables from Model I plus contralateral CVR. Model discrimination was assessed with area under the ROC curve (AUC), and model calibration with Hosmer-Lemeshow's C and calibration plots. 55 Results were adjusted for optimism using the bootstrapping techniques. 56 Uniformity of fit was evaluated across clinical grade (WFNS I-III vs. IV-V).
Statistical analysis was performed with R version 3.4.3. 57 The data that support the findings of this study are available from the corresponding author upon reasonable request.
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RESULTS
Patients, aneurysm and treatment
An overview of the source population is available in the online supplement (Table S1 ). Of 136 patients consecutively recruited during the study period, 57 were excluded, leaving a study population of 79 patients. In total, 37 patients were treated for UIA and 42 patients had aSAH (Table 1) .
Cerebrovascular reactivity
In total, 101 bilateral and 20 unilateral examinations were performed. In patients with aSAH, 84 examinations were done. Median time for first exam was 3. 
Ruptured versus unruptured aneurysms
Patients with aSAH had lower CVR compared with patients with UIA ( Figure 1 ). There was no difference in baseline velocities (MFVBASELINE) between aSAH and UIA patients ( Table 2) . Increase in velocity after AZ (ΔMFVAZ) was however smaller in patients with aSAH, yielding lower both ipsilateral and contralateral CVR.
For all patients, regardless of aneurysm rupture status, CVR was on average 5.5 percentage points lower on the ipsilateral side (p=0.04). Regression analyses (adjustment for age, sex, hypertension, smoking, aneurysm diameter and treatment modality) confirmed that CVR was lower in patients with aSAH. Patients with UIA had a single CVR measurement, whereas aSAH patients were subject to several measurements. There are thus several approaches to calculate individual CVR: the first exam, the lowest value across exams, or the within-patient average on both the ipsilateral and contralateral side. Using the first exam, the adjusted ipsilateral CVR was 19.6 percentage points lower in patients with aSAH (p=0.005), and the contralateral CVR was 16.6 percentage points lower (p=0.002). Using the lowest value across exams, the adjusted difference between the aSAH and UIA groups was 31.1 percentage points on the ipsilateral side (p<0.001), and 23.6 percentage points on the contralateral side (p<0.001). Using the within-patient average, CVR was 19.6 percentage points lower among J o u r n a l P r e -p r o o f patients with aSAH on the ipsilateral side (p=0.002) and 14.7 percentage points lower on the contralateral side (p=0.004).
Delayed cerebral ischemia and cerebral infarctions
Of 42 aSAH patients, 22 (52.4%) developed DCIclinical. Median time from ictus to diagnosis of DCIclinical was 9 days (IQR 4.8, range [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Furthermore, 19 patients (45.2%) developed DCIinfarction, and five patients (11.9%) developed infarctions from other causes ( Table 3 ). Four patients with severe, refractory radiographic vasospasm and DCIclinical were given nimodipine intrarterially as rescue therapy and survived with DCIinfarction. In all patients, angiographic vasospasm and DCIinfarction were located bilaterally or on the same side as the ruptured aneurysm. The different approaches to CVR (first exam, lowest value and within-patient average) were compared for patients with and without DCIclinical or DCIinfarction (Tables S2-S3 ). For DCIinfarction, there was no difference in ipsilateral or contralateral CVR between groups across all approaches (Table S2 ). For DCIclinical (Table S3 ), there was no difference in ipsilateral CVR between groups. However, the lowest contralateral CVR was lower in patients with DCIclinical than without (33.9% vs. 49.2%, p=0.05) and the difference in within-patient average CVR was even larger (43.2% vs. 61.9%, p=0.02). Differences in first-exam CVR were less apparent (44.0% vs. 56 .2%, p=0.19). Mean combined values of the right and left side masked side-differences between the groups. Figure 1 shows box plots illustrating the difference between ipsi-and contralateral sides.
Because CVR on the ipsilateral side was similar between patients with and without DCIclinical and DCIinfarction, contralateral CVR was selected as the exposure variable in logistic regressions ( Figure 2 ). CVR did not predict DCIinfarction, but did predict DCIclinical. For DCIclinical, OR was 0.96 for both the lowest value (95% CI 0.93-1.00, p=0.05) and within-patient average (95% CI 0.93-1.00, p=0.03). This corresponds to a 4% reduction in the odds of developing DCIclinical per percentage point increase in CVR. Hence, DCIclinical risk increased with lower J o u r n a l P r e -p r o o f contralateral CVR. The risk of developing DCIclinical is 28.3% when the lowest CVR on the contralateral side is 75%, whereas the risk is 49.0% with CVR 50% and 70.1% with CVR 25%.
The prediction models using lowest value and within-patient average were similar for DCIclinical, even though the p-value for the OR was slightly lower in the second model. Still, the lowest measured CVR is more convenient to use in clinical practice, and the time of the lowest CVR reflects the typical time period for onset of DCI. The lowest value on the contralateral side was therefore chosen as the CVR predictor for DCIclinical in the following analyses.
In prediction Model I the area under the receiver operating characteristic curve (AUC) after correction for optimism was 0.82, and in Model II the corresponding AUC was 0.86 (Table 4 ). Confidence intervals for AUC for the two models were overlapping. Receiver operating characteristic curves and calibration plots are shown in Two patients had a paradoxical velocity reduction after AZ. One patient with a single contralateral CVR of -14.9% (grey dot, Figure 2 ) developed both DCIclinical and DCIinfarction. Another patient with a negative CVR recovered without ischemic symptoms or infarction (black dot, Figure 2 ). Notably, the CVR reduction was transient, with CVR of -15.4% in the first exam and 37.4% when re-tested a week later, making the withinpatient average CVR 11.0%.
DISCUSSION
To our knowledge, this is the first study that has used TCD and AZ to compare CVR in patients with aSAH and UIA. The study indicates that contralateral CVR may be an independent predictor for clinical deterioration due to DCI after aSAH, but CVR is not able to predict radiographic infarction due to DCI.
Various methods are used to assess CVR. 58 It is unclear if CVR results are consistent for different methodologies. Comparing results by multiple methods could elucidate potential differences, but has not been done. The TCD-AZ test is widely applied for CVR testing. The method has some advantages compared with other methods (easier set-up, reduced need for patient co-operation, high safety profile), but also some J o u r n a l P r e -p r o o f disadvantages (potential side effects, dose-dependent effects, and contraindications for AZ). 58 We found that CVR was considerably lower in patients with ruptured aneurysms compared with patients with unruptured aneurysms and this difference appeared to be bigger on the ipsilateral side of aneurysm treatment. This is in concordance with previous CVR-studies using other vasoactive stimuli and measurement methods. [9] [10] [11] [12] 19 Since the 1970s, literature has suggested that impaired CVR may be associated with DCI after aSAH. [14] [15] [16] [17] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] With the exception of one study, 14 these findings are consistent across different methodologies, study designs, sample sizes, and definitions of DCI. Study sizes have however been small, and CVR has not been integrated as standard assessment after aSAH. 35, [59] [60] [61] In clinical work, a CVR based prediction model of DCI would be valuable.
In our prediction models, the confidence intervals for the coefficients of the established predictors all included the value 1 by quite some margin, whereas the confidence interval for the coefficient of CVR was 0.89 to 1.00 (Table 4 ). Note also that 0.94 is the OR per unit change in CVR, which corresponds to an OR of about 0.54 per change of 10, and an OR of 0.05 per change of 50. Among patients in our study, CVR ranges from less than zero to more than 90. Hence, contralateral CVR appears to be the strongest predictor of DCI in the model. The confidence intervals of the AUCs were overlapping, which indicates that CVR did not have additional value in the prediction of DCI after aSAH. Still, including CVR in the model caused a substantial increase of optimism adjusted AUC from 0.82 to 0.86. This warrants further investigation, especially as a more accurate prediction model for DCI is needed.
Practical considerations such as ease-of-use and patient comfort are arguments in favor of single CVR testing.
Serial testing is time consuming and can be challenging due to reduced patient co-operation, postoperative intracranial air, drains and monitoring equipment in the intensive care unit. Still, DCI has a dynamic nature, the first measured CVR had very low predictive power, and serial CVR-measurements provided added information regarding the dynamic changes in CVR throughout the acute phase after aSAH.
Overall, 52.4% of patients with aSAH in this study developed DCI. In comparison, the reported incidence of DCI is 20-35% in larger case series. 1, [62] [63] [64] [65] [66] [67] [68] [69] [70] The high frequency of DCI may reflect the high proportion of poor grade patients in our cohort, as poor clinical grade upon admission is associated with higher risk of developing J o u r n a l P r e -p r o o f DCI. Given the high proportion of patients with large bleedings and poor clinical conditions in our study, results may not be fully valid for other populations. Still, stratification for clinical grade (WFNS I-III vs. IV-V) did not cause any major changes in the prediction model.
In a previous report we argued that ipsi-and contralateral CVR should be assessed separately, as mean values can conceal side-differences. 41 One-year follow-up study indicated that patients with unruptured aneurysms had a temporary reduction in ipsilateral CVR. The present study indicates that ipsilateral CVR is reduced also after treatment for ruptured aneurysms. Ipsilateral CVR reduction thus seem to occur in all patients after aneurysm treatment, regardless of DCIclinical status. Acknowledging this side-difference enables improved interpretation of CVR after aneurysm treatment. Aneurysm treatment in itself does not induce a substantial CVR reduction on the contralateral side, making the contralateral CVR more suitable as a predictor since any DCI-related CVR reduction will be more pronounced on this side compared with the already reduced CVR on the ipsilateral side.
In concordance with the pre-existing hypothesis that CVR can predict DCI, we found impaired CVR in patients with DCIclinical. Surprisingly, we did not find an equivalent reduction in CVR in patients with DCIinfarction. This is quite a conundrum as one would expect impaired CVR for both categories of DCI, assuming clinical symptoms and infarctions are two time-points in a continuum of the same disease. The statistical power in our study may be insufficient to detect CVR impairment in patients with DCIinfarction. Still, as DCIinfarction is presumably associated with more advanced ischemia one would also expect CVR impairment to be more advanced in patients with DCIinfarction compared with DCIclinical. However, the pathophysiology of cerebral ischemia after aSAH is multifactorial and complex, 71 and it is possible that there are differences in the pathogenesis for clinical and radiographical presentations. Furthermore, we used DCIinfarction as a dichotomous variable, not taking into account the size or severity of the infarction. For ethical reasons, moribund patients and patients with increased ICP were excluded (Table S1) , this probably reduced the number of patients with severe infarctions that was tested and left a higher proportion of minor infarctions in the studied population. Additional studies with larger study sample and more comprehensive radiographical examinations including assessment of infarction size could help clarify if impaired CVR is associated with DCIinfarction or not.
There are limitations to our study. The study population is small, although the number of patients (n=42) is higher than in other neurosonological studies (median n=27, range 18-34). 14, 16, 19, 22, 30, 72, 73 were only evaluated with CT/CTA during their primary hospital stay. Still, MRI was performed in the majority of patients during follow-up. Of the 39 patients alive after one year, 36 underwent MRI; two were tourists and lost to follow-up; and one patient declined to take the exam due to claustrophobia. We used a well-known classification system for cerebral infarction. 74, 75 Still, the attribution of infarction etiology after aSAH is difficult and not easily validated, 76 kg. Still, the recommended AZ dose of 13 to 18 mg/kg 46, 77 was achieved in 91.7% of CVR tests. We used different brands of AZ, yet no difference in CVR has been found when the three manufacturers were compared. 41 A strength of our study is the methodology. Unlike the majority of previous studies, 14, 15, 17, [21] [22] [23] [24] [25] [26] [27] [28] [29] we used standardized definitions of DCI separated into clinical and radiographic findings. 38, 39 We performed serial testing, which is better adjusted to the dynamic nature of vasospasm and DCI. We also tested CVR in patients treated for UIA to increase our general understanding of CVR in patients with intracranial aneurysms. One sonographer (MLB) performed all ultrasound examinations and CVR-tests to reduce operator variability. One neuroradiologist (GM) diagnosed angiographic vasospasm and cerebral infarction, unaware of the patient's clinical and sonographic status.
Central drawbacks with regards to clinical use is that CVR testing is time consuming and that a number of patients experience side effects related to AZ, like headache, flushing, nausea or paresthesia. 20 Pretreatment CVR testing could assess potential effects on CVR caused by aneurysm treatment itself. Still, patients were not examined prior to treatment because of the potential risk of causing aneurysm (re-)rupture, and to avoid delay in the acute treatment of a ruptured aneurysm. CVR can be assessed at an earlier time in patients with UIA with assumed low rupture risk and no planned treatment, but this will not give any information about the status of cerebrovascular integrity immediately before aneurysm treatment or rupture. We did not take into account variations of intracranial pressure (ICP) or systemic blood pressure in patients with aSAH. AZ does not cause major changes in systemic blood pressure, 43, 79 but may lower ICP by reducing cerebrospinal fluid secretion. 80 AZ may also increase ICP by cerebral vasodilation 81 and may not be well suited for patients with increased ICP. These high-risk patients are closely monitored for development of DCI and AZ testing might be of less importance. In less severe cases, however, improved prediction of DCI is highly useful, and can assist medical and logistic decision making.
CONCLUSIONS
Impaired CVR on the contralateral side may be an independent predictor of DCIclinical, and may assist in identifying patients in need of closer observation after aSAH. An ipsilateral CVR reduction occurs in all patients after aneurysm treatment, regardless of DCIclinical status, highlighting the need to consider ipsilateral and contralateral CVR separately. This study underscores the value of serial CVR measurements, and future studies aiming to investigate the relationship between CVR and DCI after aSAH should take this into account. Our prediction model can be useful in clinical practice, but needs to be validated. 
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Supplementary tables S1-S3 are available on the JNS website. presented (B, D) . The solid black line shows the estimated regression line. Uncertainty is indicated by the shadowed area (95% confidence band). Two patients, marked with a solid grey and black dot, had a paradoxical velocity reduction after AZ. * Mean ± standard deviation. All other variables are reported as n (%) † Maximum diameter of the aneurysm dome. For patients with aSAH the size of the ruptured aneurysm is reported. For patients that underwent treatment for multiple UIA during the same procedure, aneurysm size was averaged ‡ Twenty-four patients with midline aneurysms (ACOM and basilar top) were allocated to the chosen side of approach. One patient treated with combined clipping of an ACOM aneurysm and a right middle cerebral artery aneurysm in one procedure was allocated to the right side. The coiling procedure failed to adequately secure the aneurysm in one patient, so clipping was performed instead. 
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